MELOXICAM 305.862 Meloxicam : translating selective COX-2 inhibition into clinical benefit. -[Philadelphia : W.B. Saunders Co. A Division of Harcourt Brace and Co.,1997]. -[6], 33 s. ; 29 cm. - (Seminars in Arthritis and Rheumatism, ISSN 0049-0172 ; vol.26,suppl.1)